Therapeutic Potential of Kappa-Opioids Against Cocaine - 1
NCT00000323 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 10
Last updated 2017-01-12
Summary
The purpose of this study is to characterize the effects of enadoline compared to hydromorphone and butorphanol.
Conditions
- Cocaine-Related Disorders
Sponsors & Collaborators
-
National Institute on Drug Abuse (NIDA)
lead NIH
Principal Investigators
-
Sharon Walsh, Ph.D. · Johns Hopkins University
Eligibility
- Min Age
- 21 Years
- Max Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 1996-07-31
- Completion
- 1998-12-31
Countries
- United States
Study Locations
More Related Trials
-
Human Dopamine Transported Imaging in Cocaine Abuse: 2 - 2
NCT00000316 ·Status: COMPLETED ·Phase: PHASE1
-
Integrated Treatment for Cocaine and Mood Disorders - 1
NCT00227812 ·Status: COMPLETED ·Phase: PHASE2
-
Naltrexone in Two Models of Psychosocial Treatments for Cocaine and Alcohol Dependence
NCT00167232 ·Status: COMPLETED ·Phase: PHASE3
-
Naltrexone in Two Models of Psychosocial Treatments for Cocaine and Alcohol Dependence - 1
NCT00218660 ·Status: COMPLETED ·Phase: PHASE3
-
Rapid Evaluation of Baclofen for Treatment of Cocaine Abuse/Dependence - 6
NCT00000303 ·Status: COMPLETED ·Phase: PHASE2
-
Effectiveness of GABA Agonists in Reducing the Reinforcing Effects of Cocaine
NCT00218166 ·Status: COMPLETED ·Phase: PHASE2
-
Impulsivity, Brain Function, and Substance Abuse Treatment in Cocaine Dependent Individuals
NCT00217997 ·Status: COMPLETED
-
Modafinil and Naltrexone to Reduce Cocaine and Alcohol Dependence
NCT00142818 ·Status: COMPLETED ·Phase: PHASE2
-
Cocaine Effects in Humans: Physiology and Behavior - 1
NCT00000200 ·Status: COMPLETED ·Phase: PHASE2
-
Stress Hormones and Human Cocaine Use - 7
NCT00000290 ·Status: COMPLETED ·Phase: PHASE1
-
Medications for Stopping Cocaine Dependence and Preventing Relapse
NCT00218023 ·Status: COMPLETED ·Phase: PHASE2
-
Assessment of Potential Interactions Between Cocaine and Tolcapone - 1
NCT00033059 ·Status: UNKNOWN ·Phase: PHASE1
-
Pharmacotherapy Dosing Regimen in Cocaine and Opiate Dependent Individuals - 8
NCT00218036 ·Status: TERMINATED ·Phase: PHASE2
-
Cocaine Opioid Oxytocin Option - Limited
NCT02028533 ·Status: COMPLETED ·Phase: PHASE1
-
A Novel Anti-Obesity Drug Combination as a Pharmacotherapy for Cocaine Dependence
NCT01739192 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Carbamazepine Treatment of Cocaine Dependence - 1
NCT00000242 ·Status: COMPLETED ·Phase: PHASE2
-
HBPL Study of the Impact of the NK1 Antagonist Aprepitant
NCT01176591 ·Status: COMPLETED ·Phase: PHASE2
-
Combination of Disulfiram Plus Naltrexone to Treat Both Cocaine- and Alcohol-dependent Individuals - 1
NCT00142844 ·Status: COMPLETED ·Phase: PHASE2
-
Baclofen for the Treatment of Cocaine Dependence - 1
NCT00082485 ·Status: COMPLETED ·Phase: PHASE2
-
Agonist Replacement Therapy for Cocaine Dependence
NCT00697138 ·Status: COMPLETED ·Phase: PHASE1
-
Dopamine Reuptake Inhibitors of Cocaine Abuse - 1
NCT00000276 ·Status: TERMINATED ·Phase: PHASE1
-
Targeting Anhedonia in Cocaine Use Disorder
NCT02773212 ·Status: COMPLETED ·Phase: PHASE2
-
Modafinil Treatment for Cocaine-Dependent Individuals
NCT00129285 ·Status: COMPLETED ·Phase: PHASE2
-
n-Acetylcysteine and Cocaine
NCT02141620 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Ondansetron for the Treatment of Cocaine Dependence - 1
NCT00033085 ·Status: COMPLETED ·Phase: PHASE2